# Cyclosporine

## Restasis 0.05% 0.4mL eye emulsion

| TAH Drug Code      | [ERES](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ERES)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Keratoconjunctivitis sicca.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Ophthalmic: Instill 1 drop in each eye twice daily (approximately 12 hours apart) Before use, turn the ampoule upside down several times to form a uniform white opaque emulsion, and then drop one drop in each eye, which can be combined with artificial liquid, but the use of two drugs should be separated by 15 minutes.                                                                                                                                                                                                                                                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Active ocular infections. Hypersensitivity to cyclosporine or any of ingredient in the formulation of the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | Common Ophthalmic: Blepharitis (Ophthalmic route 1% to 5% ), Burning sensation in eye (Ophthalmic route, 17% ), Conjunctival hyperemia (Ophthalmic route, 1% to 6% ), Eye irritation (Ophthalmic route, 1% to 5% ), Pain in eye (Ophthalmic route, emulsion 1% to 5% ; solution, 22% ) Serious Endocrine metabolic: Hyperkalemia, Hypomagnesemia Hepatic: Hepatotoxicity (7% or less ) Immunologic: Disease due to Polyomavirus Neurologic: Encephalopathy, Progressive multifocal leukoencephalopathy, Seizure (1% to 5% ) Renal: Hemolytic uremic syndrome, Nephrotoxicity (25% to 38% ) Other: Infectious disease |
| Pregnancy          | No (Limited) Human Data â€“ Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| More Info          | [UpToDate](https://www.uptodate.com/contents/cyclosporine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

